ARCHIVES

Central Line Safety Intervention Lowers Patient Infection Rate

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Report Urges NCI: No Unfunded Mandates for Cancer Centers

October 18, 1996

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

January 16, 1981